JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
Year-over-year gross profit growth rate
Percentile
P28
Within normal range
vs 2Y Ago
-4.9x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -7.92% |
| Q3 2025 | -50.96% |
| Q2 2025 | 18.31% |
| Q1 2025 | -13.09% |
| Q4 2024 | 4.16% |
| Q3 2024 | 2.35% |
| Q2 2024 | 14.64% |
| Q1 2024 | -10.57% |
| Q4 2023 | 1.62% |
| Q3 2023 | 5.27% |
| Q2 2023 | 12.95% |
| Q1 2023 | -12.09% |
| Q4 2022 | -3.76% |
| Q3 2022 | 4.85% |
| Q2 2022 | -4.32% |
| Q1 2022 | 7.29% |
| Q4 2021 | -14.87% |
| Q3 2021 | -2.18% |
| Q2 2021 | -1.76% |
| Q1 2021 | -1.40% |
| Q4 2020 | -8.94% |
| Q3 2020 | 19.99% |
| Q2 2020 | 114.97% |
| Q1 2020 | -61.41% |
| Q4 2019 | 3.70% |
| Q3 2019 | 4.04% |
| Q2 2019 | -25.57% |
| Q1 2019 | 29.25% |
| Q4 2018 | 7.33% |
| Q3 2018 | 7.66% |
| Q2 2018 | -29.36% |
| Q1 2018 | 44.17% |
| Q4 2017 | 24.69% |
| Q3 2017 | 5.56% |
| Q2 2017 | -29.33% |
| Q1 2017 | 40.93% |
| Q4 2016 | 3.85% |
| Q3 2016 | -2.49% |
| Q2 2016 | -25.08% |
| Q1 2016 | 43.95% |